GSK and Prosensa Will Hold a Joint Webinar on October 15


GSK and Prosensa will hold a joint webinar on 15th October at 16:00 – 17:30 GMT (17:00 – 18:30 CET, 12:00 – 13:30 EST, 09:00 – 10:30 PST).

Following on from the disappointing results of the phase III DMD114044 study which did not meet its primary or key secondary endpoints, GSK will share the pivotal study results which were presented at the recent World Muscle Society annual international congress and hold a live Q&A session.

In the second part of the webinar, Prosensa will discuss its other Duchenne programs and will also take live questions during the Q&A session.

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.